Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ultima Genomics
Fremont, California, United Statesultimagenomics.com ↗
- Ownership
- Private
- Employees
- ~350
- Development stage
- Commercial
01
Overview
Ultima Genomics has developed and commercialized the UG 100 sequencing platform, which enables ultra-high throughput and cost-effective DNA sequencing for applications in whole genome sequencing, oncology profiling, single cell sequencing, and proteomics. The technology supports large-scale research projects such as those by UK Biobank and Chan Zuckerberg Initiative. No clinical trial results are reported as the company does not develop therapeutics.
- Modalities
- Device (Sequencing platform)Not applicable (company provides technology/platform, not therapeutics)
- Industry
- Molecular Diagnostics
02
Partnerships
UK Biobank (“Pharma Proteomics Project”)Chan Zuckerberg Initiative (“Billion Cells Project”)Macrogen Inc. (“Certified Service Provider”)Olink® Explore HT kit integration for proteomic workflowsFabric Genomics for tertiary data analysis optimization
Beyond the preview
Go deeper on Ultima Genomics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ultima Genomics.